top of page

Mondo.NYC Speaker

Matt Phipps-Taylor

Matt Phipps-Taylor

Chief Information Officer, peermusic

Founded by Ralph S. Peer in 1928, peermusic is the world’s largest global independent music publishing and neighbouring rights administration company, operating from 38 offices in 31 countries. With well over a million titles owned or administered by the company, and with a neighbouring rights roster encompassing over 300 record labels and more than 2500 performers, peermusic is the largest privately owned company of its kind in the world. As Chief Information Officer, Matt oversees the technology and data platforms used across peermusic’s global network of companies.

Before joining peermusic, Matt was Chief Data Officer at UK neighbouring rights CMO PPL, where he oversaw data strategy, analytics and business intelligence, and led PPL’s involvement in various global industry data initiatives and partnerships. Matt also served on the board of Digital Data Exchange (DDEX), the consortium of organizations driving music data standards, and contributed to the creation of new data standards for the neighbouring rights sector.

Prior to that, Matt worked at Deloitte Consulting in the UK and US, delivering major technology and data programs for a variety of clients across the music and entertainment industries, including record labels, music publishers, societies, broadcasters and videogames.

There’s My Rights, Your Rights, and Neighboring Rights

10/12/21, 4:00 PM

Neighboring rights are as important as they are complex. Their value as an alternative revenue stream for artists and labels has grown, particularly in 2020 and 2021 as the pandemic robbed creators of live performance opportunities. Join leading legal minds and subject matter experts including SoundExchange’s Senior Director of International, Ryan Lehning, to get insights into the legal dynamics of neighboring rights, the market size, how it translates to business opportunities, and an overview of developments that could affect your income. The panel will close with Q&A and thoughts for the future of international treatment.

bottom of page